PATRICK GREGORY S

CIK 00012198441 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001219844

Recent Transactions

50 trades

Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-11-09$25.00/sh−5,000→ 44,463 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-11-09$12.98/sh+5,000→ 49,463 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-11-09−5,000→ 10,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-11-05$12.98/sh+5,000→ 49,463 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-11-05$23.00/sh−5,000→ 44,463 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-11-05−5,000→ 15,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-10-15$12.98/sh+15,000→ 59,463 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-10-15$20.03/sh−15,000→ 44,463 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-10-15−15,000→ 20,000 total
Gift
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-08-27−1,120→ 44,463 total
Gift
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-08-25−1,000→ 45,583 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-05-20−15,000→ 35,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-05-20$12.98/sh+15,000→ 61,057 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-05-20$25.03/sh−15,000→ 46,057 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-05-08$9.13/sh+15,000→ 61,057 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-05-08$23.14/sh−15,000→ 46,057 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-05-08−15,000→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2020-02-21−50,000→ 50,000 total
Gift
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2019-07-31−2,590→ 45,682 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2019-02-27$41.53/sh−20,000→ 47,896 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2019-02-27$9.13/sh+20,000→ 67,896 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2019-02-27−20,000→ 15,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2019-02-22+40,000→ 40,000 total
Gift
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2018-12-03−8,600→ 47,896 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2018-07-02$9.24/sh+20,000→ 75,975 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2018-07-02$9.13/sh+15,000→ 90,975 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2018-07-02−15,000→ 35,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2018-07-02$56.63/sh−35,000→ 55,975 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2018-07-02−20,000→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2018-02-14+30,000→ 30,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-09-08−15,000→ 25,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-09-08−23,481→ 20,000 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-08$5.88/sh+15,000→ 30,716 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-08$7.90/sh+23,481→ 39,197 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-08$48.89/sh−23,481→ 15,716 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-09-07−15,000→ 40,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-07$46.36/sh−25,000→ 2,235 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-07$48.00/sh−1,519→ 716 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-09-07−26,519→ 43,481 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-07$5.88/sh+15,000→ 15,716 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-09-07$7.90/sh+26,519→ 27,235 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-04-24$5.88/sh+50,000→ 54,221 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2017-04-24$32.37/sh−54,000→ 221 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-04-24−50,000→ 55,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2017-02-24+50,000→ 50,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2016-09-16$25.00/sh−2,000→ 3,616 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2016-07-14$22.00/sh−3,395→ 5,616 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2016-03-01+50,000→ 50,000 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2015-07-16$20.00/sh−6,217→ 7,344 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2015-03-03+50,000→ 50,000 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
VP, Chief Financial Officer
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov